However, in a study focused on redox imbalance in MASLD patients, erythrocytic SOD activity was significantly higher in patients with MASLD as compared to healthy controls (Asghari et al. 2020). Here, SOD1 is linked to metabolic dysfunction-associated steatotic liver disease.